Difluprednate(CAS: 23674-86-4)

Difluprednate (CAS: 23674-86-4) falls under the regulatory guidelines of the Chemicals Regulation Directive (CRD) in the European Union and REACH regulations. It is also subject to the Toxic Substances Control Act (TSCA) in the United States. Additionally, it is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a skin and eye irritant.

For synthesis, alternatives to Difluprednate include similar corticosteroids such as dexamethasone and hydrocortisone. Isomers like difluprednate itself and analogs like difluprednate sodium can also be considered. Common alternative reagents include corticosteroid precursors and other steroidal compounds.

The market for Difluprednate (CAS: 23674-86-4) is growing due to its use in ocular inflammatory conditions. Research trends include its efficacy and safety in various clinical settings, as well as its potential for use in other dermatological applications. Recent studies focus on its pharmacokinetics and bioavailability.

Waste containing Difluprednate (CAS: 23674-86-4) should be collected in appropriate containers and disposed of through a hazardous waste management facility. Incineration is a common method, as it ensures proper destruction of the compound. Environmental precautions include minimizing spillage and following local regulations for hazardous waste disposal.